(Q43624619)

25 November 2017

title

Combretastatin A-4 prodrug inhibits growth of human non-small cell lung cancer in a murine xenotransplant model (English)

1 reference

non-small-cell lung carcinoma

25 November 2017

1 reference

1 reference

Boehle AS

1

1 reference

25 November 2017

Sipos B

2

1 reference

25 November 2017

Kliche U

3

1 reference

25 November 2017

Kalthoff H

4

1 reference

25 November 2017

Dohrmann P

5

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

The Annals of Thoracic Surgery

25 November 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

25 November 2017

volume

71

1 reference

25 November 2017

issue

5

1 reference

25 November 2017

page(s)

1657-1665

1 reference

The international system for staging lung cancer

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902408-0

Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902408-0

Endostatin induces endothelial cell apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902408-0

Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902408-0

The interaction with tubulin of a series of stilbenes based on combretastatin A-4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902408-0

Magnetic resonance imaging and spectroscopy of combretastatin A4 prodrug-induced disruption of tumour perfusion and energetic status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902408-0

Positron emission tomography of murine liver metastases and the effects of treatment by combretastatin A-4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902408-0

Targeting the tumor vasculature with combretastatin A-4 disodium phosphate: effects on radiation therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902408-0

The effect of combretastatin A-4 disodium phosphate in a C3H mouse mammary carcinoma and a variety of murine spontaneous tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902408-0

Novel combretastatin analogues effective against murine solid tumors: design and structure-activity relationships

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902408-0

An improved orthotopic xenotransplant procedure for human lung cancer in SCID bg mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902408-0

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902408-0

Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902408-0

Combretastatin A-4 prodrug: a potent inhibitor of malignant hemangioendothelioma cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902408-0

Antitumor agents. 196. Substituted 2-thienyl-1,8-naphthyridin-4-ones: their synthesis, cytotoxicity, and inhibition of tubulin polymerization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902408-0

In vitro evaluation of the antineoplastic activity of combretastatin A-4, a natural product from Combretum caffrum (arid shrub).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902408-0

Antitumor activity of combretastatin-A4 phosphate, a natural product tubulin inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902408-0

Endothelial cell surface alkaline phosphatase activity is induced by IL-6 released during wound repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902408-0

Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2801%2902408-0

10.1016/S0003-4975(01)02408-0

7 January 2021

Identifiers

DOI

1 reference

25 November 2017

1 reference